We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
As the closely-watched opioid litigation in Ohio nears its first trial, Endo has struck a $10 million settlement and Allergan is said to be nearing its own deal.